Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
India may issue a warning over cough syrup exported by Marion Biotech linked to a death in Uzbekistan.
Read Full NewsShroff emphasizes the need to address more than just liver health in patients with alcohol-associated liver disease and reviews trends in AUD pharmacotherapy prescriptions.
With regard to safety, there were no serious adverse events (AEs) or AEs of special interest deemed related to OCU410ST reported in the study.
Specifically, the alignment relates to a separate, planned clinical trial referred to as ASPIRE.
1.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
2.
Discovery of breast cancer treatment resistance mechanism could lead to new hope for some
3.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
4.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.
5.
La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.
1.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
2.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
3.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
4.
What You Need to Know About the Early Warning Signs of Colon Cancer
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Oropharyngeal Cancer in Relation to HPV Status
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
5.
Navigating the Complexities of Ph Negative ALL - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge